Stock chart
Ticker: ALEC Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
10,898 -9.6%
21.73
236,802 USD
10,898 -9.6% 21.73 236,802 USD
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
64,102 -36.1%
21.16
1,356,347 USD
64,102 -36.1% 21.16 1,356,347 USD
Dec. 14, 2021 Dec. 10, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
8,874 -8.0%
22.33
198,192 USD
8,874 -8.0% 22.33 198,192 USD
Dec. 14, 2021 Dec. 10, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
66,126 -37.2%
21.69
1,433,975 USD
66,126 -37.2% 21.69 1,433,975 USD
Dec. 10, 2021 Dec. 9, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
2,643 -2.5%
23.40
61,858 USD
2,643 -2.5% 23.40 61,858 USD
Dec. 10, 2021 Dec. 9, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
72,357 -40.7%
22.80
1,649,986 USD
72,357 -40.7% 22.80 1,649,986 USD
Dec. 10, 2021 Dec. 8, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
38,489 -27.3%
23.01
885,690 USD
38,489 -27.3% 23.01 885,690 USD
Dec. 10, 2021 Dec. 8, 2021 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
36,511 -20.6%
22.56
823,626 USD
36,511 -20.6% 22.56 823,626 USD
Nov. 12, 2021 Nov. 11, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.7%
25.00
1,375,000 USD
55,000 -2.7% 25.00 1,375,000 USD
Nov. 12, 2021 Nov. 10, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.6%
25.00
1,375,000 USD
55,000 -2.6% 25.00 1,375,000 USD
Nov. 10, 2021 Nov. 9, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 10, 2021 Nov. 9, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 10, 2021 Nov. 9, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 10, 2021 Nov. 9, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.6%
25.00
1,375,000 USD
55,000 -2.6% 25.00 1,375,000 USD
Nov. 10, 2021 Nov. 8, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 10, 2021 Nov. 8, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 10, 2021 Nov. 8, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 10, 2021 Nov. 8, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.5%
25.00
1,375,000 USD
55,000 -2.5% 25.00 1,375,000 USD
Nov. 8, 2021 Nov. 5, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 8, 2021 Nov. 5, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 8, 2021 Nov. 5, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
375,000 USD
15,000 -2.2% 25.00 375,000 USD
Nov. 8, 2021 Nov. 5, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.4%
25.00
1,375,000 USD
55,000 -2.4% 25.00 1,375,000 USD
Nov. 8, 2021 Nov. 4, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
375,000 USD
15,000 -2.1% 25.00 375,000 USD
Nov. 8, 2021 Nov. 4, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
375,000 USD
15,000 -2.1% 25.00 375,000 USD
Nov. 8, 2021 Nov. 4, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
375,000 USD
15,000 -2.1% 25.00 375,000 USD
Nov. 8, 2021 Nov. 4, 2021 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.4%
25.00
1,375,000 USD
55,000 -2.4% 25.00 1,375,000 USD
July 8, 2021 July 7, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
17,149 -6.8%
39.32
674,220 USD
17,149 -6.8% 39.32 674,220 USD
July 8, 2021 July 7, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
7,700 -3.0%
38.14
293,686 USD
7,700 -3.0% 38.14 293,686 USD
July 8, 2021 July 7, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
4,900 -1.9%
37.41
183,332 USD
4,900 -1.9% 37.41 183,332 USD
July 8, 2021 July 6, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
1,100 -0.5%
40.01
44,016 USD
1,100 -0.5% 40.01 44,016 USD
July 8, 2021 July 6, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
10,495 -4.3%
39.20
411,411 USD
10,495 -4.3% 39.20 411,411 USD
July 8, 2021 July 6, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
3,581 -1.4%
38.55
138,059 USD
3,581 -1.4% 38.55 138,059 USD
July 8, 2021 July 6, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
1,000 -0.4%
37.43
37,434 USD
1,000 -0.4% 37.43 37,434 USD
July 8, 2021 July 6, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
3,600 -1.4%
35.95
129,433 USD
3,600 -1.4% 35.95 129,433 USD
July 8, 2021 July 6, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
10,224 -3.9%
35.10
358,813 USD
10,224 -3.9% 35.10 358,813 USD
June 21, 2021 June 16, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
4,600 -1.7%
22.18
102,049 USD
4,600 -1.7% 22.18 102,049 USD
June 21, 2021 June 15, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
30,000 -9.9%
22.07
661,953 USD
30,000 -9.9% 22.07 661,953 USD
June 10, 2021 June 8, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
800 -0.3%
20.83
16,661 USD
800 -0.3% 20.83 16,661 USD
June 10, 2021 June 8, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
2,200 -0.8%
19.89
43,753 USD
2,200 -0.8% 19.89 43,753 USD
June 10, 2021 June 8, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
16,175 -5.5%
19.00
307,331 USD
16,175 -5.5% 19.00 307,331 USD
May 25, 2021 May 21, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
14,975 -5.2%
18.14
271,681 USD
14,975 -5.2% 18.14 271,681 USD
May 20, 2021 May 18, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
4,200 -1.5%
18.04
75,786 USD
4,200 -1.5% 18.04 75,786 USD
April 8, 2021 April 7, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
45 -0.0%
19.83
892 USD
45 -0.0% 19.83 892 USD
April 8, 2021 April 7, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
22,255 -9.4%
19.19
427,158 USD
22,255 -9.4% 19.19 427,158 USD
March 24, 2021 March 23, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
13,800 -6.1%
22.21
306,498 USD
13,800 -6.1% 22.21 306,498 USD
March 24, 2021 March 22, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
5,510 -2.5%
23.55
129,774 USD
5,510 -2.5% 23.55 129,774 USD
March 24, 2021 March 22, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
24,490 -10.0%
22.85
559,601 USD
24,490 -10.0% 22.85 559,601 USD
March 10, 2021 March 9, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
19,175 -8.2%
18.12
347,405 USD
19,175 -8.2% 18.12 347,405 USD
Feb. 11, 2021 Feb. 9, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
19,175 -8.2%
20.81
399,055 USD
19,175 -8.2% 20.81 399,055 USD
Jan. 27, 2021 Jan. 26, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
27,308 -11.3%
18.00
491,544 USD
27,308 -11.3% 18.00 491,544 USD
Jan. 27, 2021 Jan. 25, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
30,000 -12.3%
18.01
540,225 USD
30,000 -12.3% 18.01 540,225 USD
Jan. 21, 2021 Jan. 20, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
8,567 -3.9%
18.00
154,211 USD
8,567 -3.9% 18.00 154,211 USD
Jan. 21, 2021 Jan. 19, 2021 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
30,000 -12.3%
18.12
543,552 USD
30,000 -12.3% 18.12 543,552 USD
July 17, 2020 July 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
378 -0.2%
23.58
8,913 USD
378 -0.2% 23.58 8,913 USD
July 17, 2020 July 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
9,622 -4.3%
22.94
220,729 USD
9,622 -4.3% 22.94 220,729 USD
June 25, 2020 June 23, 2020 S Sale

MCGUIRE TERRANCE

Non-Executive Director Major owner
4,377 -0.0%
31.54
138,063 USD
4,377 -0.0% 31.54 138,063 USD
June 25, 2020 June 23, 2020 S Sale

Polaris Venture Management Co. VI, L.L.C.

Major owner
4,377 -0.0%
31.54
138,063 USD
4,377 -0.0% 31.54 138,063 USD
June 17, 2020 June 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
3,909 -1.7%
29.90
116,879 USD
3,909 -1.7% 29.90 116,879 USD
June 17, 2020 June 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
6,091 -2.6%
29.43
179,258 USD
6,091 -2.6% 29.43 179,258 USD
June 5, 2020 June 3, 2020 PS Planned sale

Yu Calvin

Vice President, Finance

Officer
300 -0.3%
32.02
9,606 USD
300 -0.3% 32.02 9,606 USD
June 5, 2020 June 3, 2020 PS Planned sale

Yu Calvin

Vice President, Finance

Officer
1,043 -0.9%
31.04
32,375 USD
1,043 -0.9% 31.04 32,375 USD
May 19, 2020 May 15, 2020 PS Planned sale

King Robert

Chief Development Officer

Officer
3,003 -0.6%
27.78
83,423 USD
3,003 -0.6% 27.78 83,423 USD
May 19, 2020 May 15, 2020 PS Planned sale

King Robert

Chief Development Officer

Officer
8,632 -1.8%
27.02
233,237 USD
8,632 -1.8% 27.02 233,237 USD
May 19, 2020 May 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
2,104 -0.9%
27.78
58,449 USD
2,104 -0.9% 27.78 58,449 USD
May 19, 2020 May 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
5,996 -2.5%
27.00
161,892 USD
5,996 -2.5% 27.00 161,892 USD
May 19, 2020 May 15, 2020 PS Planned sale

King Robert

Chief Development Officer

Officer
3,365 -0.7%
26.24
88,298 USD
3,365 -0.7% 26.24 88,298 USD
May 19, 2020 May 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
1,900 -0.8%
26.15
49,685 USD
1,900 -0.8% 26.15 49,685 USD
April 16, 2020 April 16, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
15,086 -0.8%
23.53
354,974 USD
15,086 -0.8% 23.53 354,974 USD
April 16, 2020 April 16, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
47,097 -0.8%
23.53
1,108,192 USD
47,097 -0.8% 23.53 1,108,192 USD
April 17, 2020 April 15, 2020 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
10,000 -3.9%
22.27
222,700 USD
10,000 -3.9% 22.27 222,700 USD
April 16, 2020 April 14, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
5,636 -0.3%
23.52
132,559 USD
5,636 -0.3% 23.52 132,559 USD
April 16, 2020 April 14, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
17,595 -0.3%
23.52
413,834 USD
17,595 -0.3% 23.52 413,834 USD
April 9, 2020 April 9, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
69,893 -3.5%
23.79
1,662,754 USD
69,893 -3.5% 23.79 1,662,754 USD
April 9, 2020 April 9, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
218,208 -3.5%
23.79
5,191,168 USD
218,208 -3.5% 23.79 5,191,168 USD
April 9, 2020 April 8, 2020 S Sale

ORBIMED ADVISORS LLC

Major owner
20,041 -1.0%
23.65
473,970 USD
20,041 -1.0% 23.65 473,970 USD